Literature DB >> 28811124

Two cap residues in the S1 subsite of a Plasmodium falciparum M1-family aminopeptidase promote broad specificity and enhance catalysis.

Matthew Rosati1, Seema Dalal1, Michael Klemba2.   

Abstract

The aminopeptidase PfA-M1 is a key contributor to peptide catabolism in the human malaria parasite Plasmodium falciparum. PfA-M1 substrate specificity is shaped by the cylindrical S1 subsite, which accommodates the sidechain of the substrate P1 residue. At the top of the S1 subsite are two "cap" residues, E572 and M1034, that are positioned to influence S1 subsite specificity. In this study, we have mutated the cap residues, individually and together, and have evaluated the effects on PfA-M1 specificity and catalytic efficiency. When the P1 residue was too small to engage the cap residues, the mutations had no effect on catalysis. Hydrolysis of dipeptide substrates with a basic P1 residue was significantly impaired in the E572A mutant, most likely due to the loss of a stabilizing salt bridge between E572 and the P1 sidechain. With M1034A, a substantial reduction in catalytic efficiency was observed when the P1 sidechain was large and non-polar. The double E572A/M1034A exhibited significant decreases in catalytic efficiency for most substrates. This effect was not reversed with the polar substitutions E572N/M1034Q, which replaced the PfA-M1 cap residues with those of Escherichia coli aminopeptidase N. Both E572 and M1034 contributed to the binding of the competitive aminopeptidase inhibitor bestatin.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aminopeptidase; Enzyme; Malaria; Specificity

Mesh:

Substances:

Year:  2017        PMID: 28811124      PMCID: PMC5633526          DOI: 10.1016/j.molbiopara.2017.08.001

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  27 in total

1.  Design, synthesis and antimalarial activity of novel, quinoline-based, zinc metallo-aminopeptidase inhibitors.

Authors:  Marian Flipo; Isabelle Florent; Philippe Grellier; Christian Sergheraert; Rebecca Deprez-Poulain
Journal:  Bioorg Med Chem Lett       Date:  2003-08-18       Impact factor: 2.823

2.  The determination of enzyme inhibitor constants.

Authors:  M DIXON
Journal:  Biochem J       Date:  1953-08       Impact factor: 3.857

3.  Potent dual inhibitors of Plasmodium falciparum M1 and M17 aminopeptidases through optimization of S1 pocket interactions.

Authors:  Nyssa Drinkwater; Natalie B Vinh; Shailesh N Mistry; Rebecca S Bamert; Chiara Ruggeri; John P Holleran; Sasdekumar Loganathan; Alessandro Paiardini; Susan A Charman; Andrew K Powell; Vicky M Avery; Sheena McGowan; Peter J Scammells
Journal:  Eur J Med Chem       Date:  2016-01-13       Impact factor: 6.514

Review 4.  Hemoglobin degradation.

Authors:  D E Goldberg
Journal:  Curr Top Microbiol Immunol       Date:  2005       Impact factor: 4.291

5.  Novel selective inhibitors of the zinc plasmodial aminopeptidase PfA-M1 as potential antimalarial agents.

Authors:  Marion Flipo; Terence Beghyn; Virginie Leroux; Isabelle Florent; Benoit P Deprez; Rebecca F Deprez-Poulain
Journal:  J Med Chem       Date:  2007-02-28       Impact factor: 7.446

6.  Structural basis for the inhibition of the essential Plasmodium falciparum M1 neutral aminopeptidase.

Authors:  Sheena McGowan; Corrine J Porter; Jonathan Lowther; Colin M Stack; Sarah J Golding; Tina S Skinner-Adams; Katharine R Trenholme; Franka Teuscher; Sheila M Donnelly; Jolanta Grembecka; Artur Mucha; Pawel Kafarski; Ross Degori; Ashley M Buckle; Donald L Gardiner; James C Whisstock; John P Dalton
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-05       Impact factor: 11.205

7.  Distribution and biochemical properties of an M1-family aminopeptidase in Plasmodium falciparum indicate a role in vacuolar hemoglobin catabolism.

Authors:  Daniel Ragheb; Seema Dalal; Kristin M Bompiani; W Keith Ray; Michael Klemba
Journal:  J Biol Chem       Date:  2011-06-09       Impact factor: 5.157

Review 8.  Plasmodium falciparum M1-aminopeptidase: a promising target for the development of antimalarials.

Authors:  Jorge González-Bacerio; Rafael Fando; Alberto del Monte-Martínez; Jean-Louis Charli; María de los Á Chávez
Journal:  Curr Drug Targets       Date:  2014       Impact factor: 3.465

9.  On the size of the active site in proteases. I. Papain.

Authors:  I Schechter; A Berger
Journal:  Biochem Biophys Res Commun       Date:  1967-04-20       Impact factor: 3.575

10.  A naturally variable residue in the S1 subsite of M1 family aminopeptidases modulates catalytic properties and promotes functional specialization.

Authors:  Seema Dalal; Daniel R T Ragheb; Florian D Schubot; Michael Klemba
Journal:  J Biol Chem       Date:  2013-07-29       Impact factor: 5.157

View more
  2 in total

1.  Aminobenzosuberone Scaffold as a Modular Chemical Tool for the Inhibition of Therapeutically Relevant M1 Aminopeptidases.

Authors:  Emmanuel Salomon; Marjorie Schmitt; Anil Kumar Marapaka; Athanasios Stamogiannos; Germain Revelant; Céline Schmitt; Sarah Alavi; Isabelle Florent; Anthony Addlagatta; Efstratios Stratikos; Céline Tarnus; Sébastien Albrecht
Journal:  Molecules       Date:  2018-10-11       Impact factor: 4.411

2.  Steered molecular dynamics simulations reveal critical residues for (un)binding of substrates, inhibitors and a product to the malarial M1 aminopeptidase.

Authors:  Daniel S Moore; Conor Brines; Heather Jewhurst; John P Dalton; Irina G Tikhonova
Journal:  PLoS Comput Biol       Date:  2018-10-31       Impact factor: 4.475

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.